About
Clinical Research, Regulatory Development
Areas of Focus
Categories
Clinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchSan Diego & Southern California
Team (7)
Casey Ustick
Casey Ustick
ProSciento
team_member
Executive Leadership
ProSciento
team_member
Helge Guenther
Helge Guenther
ProSciento
team_member
Janet Reardon
Janet Reardon, GPHR, SHRM-SCP
ProSciento
team_member
Marcus Hompesch
Marcus Hompesch, M.D.
ProSciento
team_member
Megan McCormick
Megan McCormick
ProSciento
team_member
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
0
As Collaborator
6
Total Enrollment
303
By Phase
PHASE1: 2PHASE2: 1NA: 1PHASE1/PHASE2: 2
By Status
COMPLETED: 5TERMINATED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT06036784Collaborator
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects
PHASE1Completed
69 participants
Started: Sep 18, 2023 · Completed: Dec 5, 2024
NCT04956263Collaborator
A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 Diabetes
PHASE2Completed
19 participants
Started: Jun 17, 2021 · Completed: Jul 19, 2022
NCT04502212Collaborator
Pilot Study to Assess the Effects of Hepatic Ultrasound Insonification on Subjects With T2DM
NACompleted
16 participants
Started: Jul 30, 2020 · Completed: May 24, 2021
NCT04048135Collaborator
A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH
PHASE1/PHASE2Completed
101 participants
Started: Jul 29, 2019 · Completed: Jan 19, 2022
NCT04004325Collaborator
A Study of FT 4101 in Overweight/Obese Participants With Non-alcoholic Steatohepatitis
PHASE1/PHASE2Terminated
14 participants
Started: May 17, 2019 · Completed: Jan 20, 2020
Locations (1)
Headquarters
Chula Vista, CA, United States
Map
Loading map...